iKNiTO Journal Management System
Toggle navigation
Home
Volume & Issue:
Volume 4, Issue 4, 2017, Page 1-108
1
Treatment and prognosis of Primary CNS lymphoma
Page
9-10
Haitham M AbdelBary
View Article
|
PDF
621.91 K
|
View on SCiNiTO
2
ALL Management Guideline
Page
11-14
Rania A Radwan
View Article
|
PDF
854.8 K
|
View on SCiNiTO
3
Perioperative Management of Anticoagulants and Antiplatelets
Page
15-17
Haydi M Mohamed
View Article
|
PDF
1.5 MB
|
View on SCiNiTO
4
Diffuse large B -Cell Lymphoma ESMO Summary of recommendations
Page
18-20
Mohamed A Shazly
View Article
|
PDF
959.23 K
|
View on SCiNiTO
5
NCCN and ESMO guidelines For the diagnosis and management of AML
Page
21-23
Nour Elhoda Hussein
View Article
|
PDF
801.54 K
|
View on SCiNiTO
6
AASLD 2016 Recommendations for Testing, Managing, and Treating Hepatitis C
Page
24-27
Rasha Kamel
View Article
|
PDF
838.38 K
|
View on SCiNiTO
7
Capsule summary of NCCN Guidelines for Hodgkin Lymphoma
Page
28-31
Mary Gamal
View Article
|
PDF
673.01 K
|
View on SCiNiTO
8
Multiple Myeloma Guidelines adopted from NCCN and ESMO
Page
32-37
Nahid Meowad
View Article
|
PDF
1.28 MB
|
View on SCiNiTO
9
Immunotherapy in ALL: from Bench to Bedside
Page
39-48
Rania A Radwan
View Article
|
PDF
1.03 MB
|
View on SCiNiTO
10
Perioperative Management of Anticoagulants and Anti-Platelets
Page
49-59
Haydi M Mohamed
View Article
|
PDF
1.16 MB
|
View on SCiNiTO
11
Chemotherapy-Induced Nausea and Vomiting (CINV)
Page
60-68
Mohamed A Shazly
View Article
|
PDF
791.57 K
|
View on SCiNiTO
12
Management of FLT-3 mutated AML
Page
69-75
Nour Elhoda Hussein
View Article
|
PDF
667.96 K
|
View on SCiNiTO
13
How I treat hepatitis C virus infection in patients with hematologic malignancies
Page
76-86
Rasha Kamel
View Article
|
PDF
802.69 K
|
View on SCiNiTO
14
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Page
87-95
Mary Gamal
View Article
|
PDF
882.69 K
|
View on SCiNiTO
15
The impact of microbiota on hematological disorders
Page
96-107
Nahid Meowad
View Article
|
PDF
789.33 K
|
View on SCiNiTO